These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26646038)

  • 1. Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.
    Vandenberghe F; Gholam-Rezaee M; Saigí-Morgui N; Delacrétaz A; Choong E; Solida-Tozzi A; Kolly S; Thonney J; Gallo SF; Hedjal A; Ambresin AE; von Gunten A; Conus P; Eap CB
    J Clin Psychiatry; 2015 Nov; 76(11):e1417-23. PubMed ID: 26646038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic agents and the prediction of weight gain.
    Tohen M
    J Clin Psychiatry; 2015 Nov; 76(11):e1474-5. PubMed ID: 26646044
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
    Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
    Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Side effects or predictor of the therapy success? Psychotropic drugs as fattener].
    MMW Fortschr Med; 2004 Jan; 146(1-2):8. PubMed ID: 18441570
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in Psychiatry (MiP) Study.
    Barton BB; Zagler A; Engl K; Rihs L; Musil R
    Eur Arch Psychiatry Clin Neurosci; 2020 Aug; 270(5):597-609. PubMed ID: 31302731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric medication-induced obesity: a review.
    Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
    Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population.
    Choong E; Bondolfi G; Etter M; Jermann F; Aubry JM; Bartolomei J; Gholam-Rezaee M; Eap CB
    J Psychiatr Res; 2012 Apr; 46(4):540-8. PubMed ID: 22316639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.
    Vandenberghe F; Saigí-Morgui N; Delacrétaz A; Quteineh L; Crettol S; Ansermot N; Gholam-Rezaee M; von Gunten A; Conus P; Eap CB
    Pharmacogenet Genomics; 2016 Dec; 26(12):547-557. PubMed ID: 27741037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight gain in the treatment of mood disorders.
    Aronne LJ; Segal KR
    J Clin Psychiatry; 2003; 64 Suppl 8():22-9. PubMed ID: 12892538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of adipose tissue in female in-patients receiving psychotropic drugs.
    Stedman T; Welham J
    Br J Psychiatry; 1993 Feb; 162():249-50. PubMed ID: 8094639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of obesity-related care by psychiatric patients.
    Copeland LA; Pugh MJ; Hicks PB; Noel PH
    Psychiatr Serv; 2012 Mar; 63(3):230-6. PubMed ID: 22307880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.
    Zimmermann U; Kraus T; Himmerich H; Schuld A; Pollmächer T
    J Psychiatr Res; 2003; 37(3):193-220. PubMed ID: 12650740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
    Quteineh L; Vandenberghe F; Saigi Morgui N; Delacrétaz A; Choong E; Gholam-Rezaee M; Magistretti P; Bondolfi G; Von Gunten A; Preisig M; Castelao E; Vollenweider P; Waeber G; Bochud M; Kutalik Z; Conus P; Eap CB
    Pharmacogenet Genomics; 2015 May; 25(5):246-58. PubMed ID: 25751397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Why getting fat, Doc?' Weight gain and psychotropic medications.
    Malhi GS; Mitchell PB; Caterson I
    Aust N Z J Psychiatry; 2001 Jun; 35(3):315-21. PubMed ID: 11437804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain.
    Vandenberghe F; Najar-Giroud A; Holzer L; Conus P; Eap CB; Ambresin AE
    J Child Adolesc Psychopharmacol; 2018 May; 28(4):258-265. PubMed ID: 29297696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain associated with taking psychotropic medication: an integrative review.
    McCloughen A; Foster K
    Int J Ment Health Nurs; 2011 Jun; 20(3):202-22. PubMed ID: 21492360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationships among psychiatric medications, eating behaviors, and weight.
    Davison KM
    Eat Behav; 2013 Apr; 14(2):187-91. PubMed ID: 23557818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic drug considerations in depressed patients with metabolic disturbances.
    Vieweg WV; Levy JR; Fredrickson SK; Chipkin SR; Beatty-Brooks M; Fernandez A; Hasnain M; Pandurangi AK
    Am J Med; 2008 Aug; 121(8):647-55. PubMed ID: 18691474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.